Thompson Siegel & Walmsley’s NuVasive, Inc. NUVA Stock Holding History

Thompson Siegel & Walmsley’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-17	Closed	-$1K	–	910
2017 Q1	$1K	Hold	17	–	–	﹤0.01%	835
2016 Q4	$0	Buy	+17	New	+$1.1K	﹤0.01%	918

Other funds holding NUVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Thompson Siegel & Walmsley's NUVA Position: Q2 2017 in Review

Thompson Siegel & Walmsley sold out of NuVasive, Inc. (NUVA) in Q2 2017, closing a stake of 17 shares — an estimated $1K sold.

Thompson Siegel & Walmsley first reported a position in NUVA in Q4 2016 and held it in 2 quarters. The position peaked at $1K in Q1 2017. 298 funds tracked by Wall St. Rank hold NUVA as of Q2 2017.

Thompson Siegel & Walmsley reported no remaining NuVasive, Inc. position as of Q2 2017 after selling out during the quarter.
Thompson Siegel & Walmsley sold 17 NuVasive, Inc. shares in Q2 2017, an estimated $1K.
Thompson Siegel & Walmsley first reported a position in NuVasive, Inc. in Q4 2016 and held it in 2 quarters.
Thompson Siegel & Walmsley's NuVasive, Inc. position peaked at $1K in Q1 2017.
298 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2017.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2017, filed 9 Aug 2017.